Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Chien

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Neuropsychobiology|January 1, 1996
Plasma haloperidol and reduced haloperidol concentrations in a geriatric populationW H Chang, M W Jann, T S Chiang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1993
Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenicsW H Chang, S K Lin, D J Juang, et al.
Schizophrenia Research|March 1, 1993
Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawalW H Chang, S K Lin, D J Juang, et al.
Schizophrenia Research|October 1, 1993
Plasma homovanillic acid and treatment response in a large group of schizophrenic patientsW H Chang, H G Hwu, T Y Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1992
Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populationsM W Jann, W H Chang, Y W Lam, et al.
Journal of Clinical Pharmacology|October 1, 1996
Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophreniaH F Huang, M W Jann, F C Wei, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Neuropsychobiology|January 1, 1996
Plasma haloperidol and reduced haloperidol concentrations in a geriatric populationW H Chang, M W Jann, T S Chiang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1993
Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenicsW H Chang, S K Lin, D J Juang, et al.
Schizophrenia Research|March 1, 1993
Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawalW H Chang, S K Lin, D J Juang, et al.
Schizophrenia Research|October 1, 1993
Plasma homovanillic acid and treatment response in a large group of schizophrenic patientsW H Chang, H G Hwu, T Y Chen, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1992
Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populationsM W Jann, W H Chang, Y W Lam, et al.
Journal of Clinical Pharmacology|October 1, 1996
Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophreniaH F Huang, M W Jann, F C Wei, et al.
Pageof 4